Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 122 of the 134 references it cites were found in a registry or an index; 13 of the 22 sources its claims cite were checked for support.

Investigating the impact of trial retractions on the healthcare evidence ecosystem (VITALITY Study I): retrospective cohort study

Open access

Abstract

Objective: To investigate the impact of retracted trials on the production and use of healthcare evidence in the evidence ecosystem. Design: Retrospective cohort study based on forward citation searching. Data sources: Retraction Watch up to 5 November 2024. Study selection: Randomised controlled trials in humans that were retracted for any reason. Methods: Forward citation searching via Google Scholar and Scopus was used to identify evidence synthesis research (21 November 2024) that quantitatively incorporated retracted trials. Data were independently extracted by two groups of researchers. The results of meta-analyses were updated after exclusion of the retracted trials. The proportions of meta-analyses that changed direction of the pooled effect and/or the significance of the P value were estimated. A generalised linear mixed model was used to investigate the association between the number of included studies and the impact, measured by odds ratio and 95% confidence interval (CI). The impact of distorted evidence on clinical practice guidelines was also investigated on the basis of citation searching. Results: The searches identified 1330 retracted trials and 847 systematic reviews that quantitatively synthesised retracted trials, with a total of 3902 meta-analyses that could be replicated. After the potential clustering effects were accounted for, the exclusion of the retracted trials led to a change in the direction of the pooled effect in 8.4% (95% CI 6.8% to 10.1%), in its statistical significance in 16.0% (14.2% to 17.9%), and in both direction and significance in 3.9% (2.5% to 5.2%) and a >50% change in the magnitude of the effect in 15.7% (13.5% to 17.9%). An obvious non-linear association existed between the number of included studies and the impact on the results, with a lower number of studies having higher impact (eg, for 10 studies versus ≥20 studies, change of direction: odds ratio 2.63, 95% CI 1.29 to 5.38; P<0.001). Evidence from 68 systematic reviews with conclusions distorted by retracted trials was used in 157 guideline documents. Conclusion: Retracted trials have a substantial impact on the evidence ecosystem, including evidence synthesis, clinical practice guidelines, and evidence based clinical practice. Evidence generators, synthesisers, and users must pay attention to this problem, and feasible approaches that assist with easier identification and correction of such potential contamination are needed. Study registration: Open Science Framework ( https://osf.io/7eazq/ ).

Overview

CoChat Summary

## TL;DR

This retrospective cohort study used forward citation searching to trace how 1,330 retracted randomized trials propagated through systematic reviews and clinical practice guidelines. Excluding retracted trials changed pooled results in a meaningful minority of meta-analyses, showing a contamination cascade from trials to guidelines.

## Key findings

  • The searches identified 1,330 retracted trials, 847 systematic reviews that quantitatively synthesized them, and 3,902 pair-wise meta-analyses that could be replicated.
  • After excluding retracted trials, the pooled effect changed in 8.4% of meta-analyses, the P value significance changed in 16.0%, both direction and significance changed in 3.9%, and the effect magnitude changed by >50% in 15.7%.
  • Meta-analyses with fewer studies were more affected; for 10 studies versus ≥20 studies, the odds of a change in direction were 2.63 (95% CI 1.29 to 5.38; P<0.001).
  • Of the 1,330 retracted trials, 312 (23.5%) contaminated 4,095 meta-analyses from 847 systematic reviews, and 218 substantially affected meta-analyses from 68 systematic reviews were used in 157 English-language guideline documents.

## Methods

  • Design: Retrospective cohort study based on forward citation searching; a pre-specified protocol was registered on 13 April 2023.
  • Data/sample: Retracted human randomized controlled trials from Retraction Watch (updated to 5 November 2024), then systematic reviews/meta-analyses found via Google Scholar and Scopus, plus English-language clinical practice guidelines potentially affected by contaminated reviews.
  • Main analysis: Two groups independently extracted data; three methodologists replicated meta-analyses, re-ran them after excluding retracted trials, and estimated the proportions with changed direction, changed statistical significance, both, or >50% change in magnitude using a generalised linear mixed model with clustering and subgroup analyses.

## Limitations

  • The paper states that it could underestimate affected guidelines because some guidelines were not indexed, some were not in included languages, and some used trial evidence directly rather than through reviews.
  • It also states that it focused only on pair-wise meta-analyses and on retracted randomized trials, so effects on network meta-analyses and non-randomized studies were not assessed.
  • Evident from the text: the study relied on forward citation searching and reported that 193/4,095 (4.7%) meta-analyses could not be exactly reconstructed, which may mean some relevant evidence or exact model details were missed.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1136/bmj-2024-082068

Cites

122 of 122 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig 1 Flowchart of selection of retracted trials. RCT=randomised controlled trial; SR=systematic review
Fig 1 Flowchart of selection of retracted trials. RCT=randomised controlled trial; SR=systematic reviewCC BY · PubMed Central
Fig 2 Impact of retracted trials on evidence synthesis research
Fig 2 Impact of retracted trials on evidence synthesis researchCC BY · PubMed Central
Fig 3 Contamination chain of retracted trials on evidence ecosystem
Fig 3 Contamination chain of retracted trials on evidence ecosystemCC BY · PubMed Central

Verification

Claims the paper makes

6 Valid · 2 Not valid · 7 Not checked · 77 Own results and interpretations

33 more claims

Create a free account to see all 92 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 22
  • It may state two separate claims as one. 40
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Self-check results appear here once an independent check has confirmed them.

Cited works that were retracted

Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.

6 of 6

Citations

Cites

6 retracted

Show all 134 references

Research works printed but not linked: 2

  1. 10.1111/jog.12393 · DOI
  2. 10.1097/MJT.0000000000000011 · DOI

Cited by

See all 40

Metadata

Authors
Xu, C., Fan, S., Tian, Y., Liu, F., Furuya-Kanamori, L., Clark, J., Zhang, C., Li, S., Lin, L., Chu, H., Li, S., Golder, S., Loke, Y., Vohra, S., Glasziou, P., Doi, S. A., & Liu, H.
Affiliations
  • Eastern Hepatobiliary Surgery Hospital (CN)
  • Second Military Medical University (CN)
  • Bond University (AU)
  • Hubei University of Medicine (CN)
  • Sichuan University (CN)
  • University of Arizona (US)
  • University of Minnesota (US)
  • University of York (GB)
  • University of East Anglia (GB)
  • University of Alberta (CA)
  • Qatar University (QA)
Corresponding author
Liu, Hui
Venue
BMJ
Publisher
BMJ
Published
2025-04-23
Volume
389
Pages
e082068
ISSN
1756-1833 (ISSN-L)
OpenAlex
W4409776768
Cited by
39
References
134
Citations by year
2026: 29 · 2025: 10
FWCI
24.73
Type
journal article
Language
en
Open access
Locations
  • BMJ (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion, cc-by)
  • UEA Digital Repository (University of East Anglia) (acceptedVersion, cc-by)
  • Bond University Research Portal (Bond University) (submittedVersion, cc-by)
  • Qatar University QSpace (Qatar University) (submittedVersion)
Funders
Qatar National Research Fund
Topics
  • Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
  • Social Sciences › Education › Academic integrity and plagiarism
  • Social Sciences › Library and Information Sciences › Academic Publishing and Open Access
Keywords
research integrity, evidence synthesis, meta-analysis, systematic reviews, evidence-based care, citation analysis, evidence ecosystem, research misconduct, publication bias, evidence-based medicine training
MeSH terms
Humans, Retrospective Studies, Meta-Analysis as Topic, Randomized Controlled Trials as Topic, Evidence-Based Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-01, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-01 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Investigating the impact of trial retractions on the healthcare evidence ecosystem (VITALITY Study I): retrospective cohort study. https://app.cochat.ai/papers/10.1136/bmj-2024-082068
The paper
Xu, C., Fan, S., Tian, Y., Liu, F., Furuya-Kanamori, L., Clark, J., Zhang, C., Li, S., Lin, L., Chu, H., Li, S., Golder, S., Loke, Y., Vohra, S., Glasziou, P., Doi, S. A., & Liu, H. (2025). Investigating the impact of trial retractions on the healthcare evidence ecosystem (VITALITY Study I): retrospective cohort study. BMJ. https://doi.org/10.1136/bmj-2024-082068

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.